Trial intelligence / Profile preview

Bimatoprost in Glaucoma or Ocular Hypertension

NCT00538304Phase 2Completed

Sponsor
Allergan
Start
Nov 2007
Primary completion
May 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Allergan. Started Nov 2007; status: completed.

02

Drugs

bimatoprost
03

Conditions

Glaucomaocular hypertension

Beyond the preview

Go deeper on NCT00538304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00538304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call